Key result
Ischemic heart disease caused ~298,000 DALYs in Tabasco, Mexico, surging during the COVID-19 pandemic.
Why the study?
Ischemic heart disease carries significant global and national incidence and mortality, motivating an analysis of its disease burden in Tabasco, Mexico.
Observational (n=927,000)
The burden of ischemic heart disease in Tabasco, Mexico, significantly increased from 2013 to 2021, highlighting a growing public health challenge exacerbated by the COVID-19 pandemic.
Answers are grounded in this paper and cite their sources.
Rising IHD burden in Tabasco warrants regional vigilance; extends observational data but leaves open pandemic causality.
INTRODUCTION: The burden of disease measures the total impact of diseases on a population, considering incidence, prevalence, disability, and premature mortality. This study analyzes the burden of ischemic heart disease (IHD) in Tabasco, Mexico, from 2013 to 2021. Ischemic heart disease has a significant incidence of 21,203,479 cases worldwide, and nationally (inside Mexico) a total of 221,747 cases, with more than 9,137,791 deaths due to this pathology globally. OBJECTIVE: To analyze the burden of ischemic heart disease in Tabasco, Mexico, during the 2013-2021 period. METHODS: An observational, descriptive, longitudinal, and retrospective study was conducted in Tabasco. The study population consisted of 2,402,598 people according to INEGI, with a sample of 927,000 adults (462,000 men and 465,000 women). Data were used from the General Directorate of Health Information, IHME, and the World Bank. Analyses were performed in Microsoft Excel, calculating measures of central tendency, dispersion, and Disability-Adjusted Life Years (DALYs). RESULTS: The DALYs in the adult population of Tabasco were: 2013-23,932; 2014-28,132; 2015-30,197; 2016-30,683; 2017-31,839; 2018-38,599; 2019-40,046; 2020-42,307; and 2021-55,723, totaling 297,576 DALYs from 2013 to 2021. DISCUSSION: Ischemic heart disease increased in incidence and mortality in both men and women during the years analyzed. The increase in DALYs indicates a greater impact of ischemic heart disease in Tabasco compared to countries like Costa Rica. CONCLUSION: The burden of ischemic heart disease from 2013 to 2021 represents a significant loss of quality and years of life in the population of Tabasco, Mexico.
No takes yet. Share an insight, caveat, or question.
Cárdenas-Anguiano et al. (2025) conducted an observational in Ischemic heart disease (n=927,000). Ischemic heart disease was evaluated on Disability-Adjusted Life Years (DALYs). The burden of ischemic heart disease in Tabasco, Mexico, resulted in a total of 297,576 Disability-Adjusted Life Years (DALYs) from 2013 to 2021, with a marked increase during the COVID-19 pandemic.
Synapse has enriched 10 related papers. Consider them for comparative context: